BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28496746)

  • 21. Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety.
    Salim I; Al Suwaidi J; Ghadban W; Salam AM
    Expert Opin Drug Saf; 2013 Jan; 12(1):53-63. PubMed ID: 23095103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).
    Lip GY; Laroche C; Ioachim PM; Rasmussen LH; Vitali-Serdoz L; Petrescu L; Darabantiu D; Crijns HJ; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP; Boriani G
    Eur Heart J; 2014 Dec; 35(47):3365-76. PubMed ID: 25176940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial fibrillation and chronic kidney disease: struggling through thick and thin.
    Gill S; Jun M; Ravani P
    Nephrol Dial Transplant; 2017 Jul; 32(7):1079-1084. PubMed ID: 27742825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of patients with atrial fibrillation and chronic kidney disease in light of the latest guidelines.
    Młodawska E; Tomaszuk-Kazberuk A; Łopatowska P; Musiał WJ; Małyszko J
    Pol Arch Med Wewn; 2016 May; 126(5):353-62. PubMed ID: 27243343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-thrombotic therapy for atrial fibrillation in patients with chronic kidney disease: Current views.
    Ghadban R; Flaker G; Katta N; Alpert MA
    Hemodial Int; 2017 Oct; 21 Suppl 2():S47-S56. PubMed ID: 29064182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Same rhythm, different song-approaches to atrial fibrillation management by cardiologists and nephrologists.
    Mark PB; Vecchio LD; Valdivielso JM; Malyszko J
    Clin Kidney J; 2021 Jan; 14(1):9-13. PubMed ID: 33564401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does Atrial Fibrillation Increase the Risk of Developing End-stage Renal Disease in Patients with Chronic Kidney Disease?
    Suwanwongse K; Shabarek N
    Cureus; 2020 Feb; 12(2):e6908. PubMed ID: 32190463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease.
    Nishimura M; Hsu JC
    Am J Cardiol; 2018 Jan; 121(1):131-140. PubMed ID: 29132650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of atrial fibrillation.
    Bajpai A; Savelieva I; Camm AJ
    Br Med Bull; 2008; 88(1):75-94. PubMed ID: 19059992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry.
    Esteve-Pastor MA; Rivera-Caravaca JM; Roldán-Rabadán I; Roldán V; Muñiz J; Raña-Míguez P; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
    Thromb Haemost; 2018 Feb; 118(2):279-287. PubMed ID: 29443369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
    Ha JT; Neuen BL; Cheng LP; Jun M; Toyama T; Gallagher MP; Jardine MJ; Sood MM; Garg AX; Palmer SC; Mark PB; Wheeler DC; Jha V; Freedman B; Johnson DW; Perkovic V; Badve SV
    Ann Intern Med; 2019 Aug; 171(3):181-189. PubMed ID: 31307056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment.
    Hawkins NM; Jhund PS; Pozzi A; O'Meara E; Solomon SD; Granger CB; Yusuf S; Pfeffer MA; Swedberg K; Petrie MC; Virani S; McMurray JJ
    Eur J Heart Fail; 2016 Sep; 18(9):1162-71. PubMed ID: 27594177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials.
    Proietti M; Lane DA; Lip GYH
    EBioMedicine; 2016 Jun; 8():309-316. PubMed ID: 27428440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.
    Tan J; Liu S; Segal JB; Alexander GC; McAdams-DeMarco M
    BMC Nephrol; 2016 Oct; 17(1):157. PubMed ID: 27769175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease.
    Bhatia HS; Bailey J; Unlu O; Hoffman K; Kim RJ
    Pacing Clin Electrophysiol; 2019 Nov; 42(11):1463-1470. PubMed ID: 31599969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).
    Poli D; Antonucci E; Zanazzi M; Grifoni E; Testa S; Ageno W; Palareti G
    Thromb Haemost; 2012 Jun; 107(6):1100-6. PubMed ID: 22535516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week.
    Kumar S; Lim E; Covic A; Verhamme P; Gale CP; Camm AJ; Goldsmith D
    J Am Coll Cardiol; 2019 Oct; 74(17):2204-2215. PubMed ID: 31648714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry.
    Deng H; Shantsila A; Xue Y; Bai Y; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Wu S; Lip GYH
    Arch Cardiovasc Dis; 2019; 112(6-7):420-429. PubMed ID: 31133543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Prevalent and Incident Atrial Fibrillation on Renal Outcome, Cardiovascular Events, and Mortality in Patients with Chronic Kidney Disease.
    Hsu HH; Kor CT; Hsieh YP; Chiu PF
    J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31484322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.